Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Starling Oncology, Inc. (STLN) Q3 2026 Earnings Call Transcript
Oncology Institute Q3 Earnings Call Highlights
Starling Oncology, Inc. (STLN) Reports Q3 Loss, Beats Revenue Estimates
Starling Oncology Reports Third Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance
Starling Oncology Announces Third Quarter 2026 Earnings Release Date and Conference Call
Oncology Institute (NASDAQ:STLN) Shares Climb 6.1% – Should You Buy?
Cedar Grove Capital Q3 2026 Portfolio Update
Starling Oncology Leadership Highlights Recent and Upcoming Industry Conference Participation
Starling Oncology: Improving Cash Flow And Gross Profit Fuel A Re-Rating
Starling Oncology to Participate in Wells Fargo Healthcare Conference
Starling Oncology Launches Starling Nexus™, a Technology Platform Built to Optimize Oncology Provider Engagement and Accelerate High-Quality Care at Scale
Starling Oncology, Inc. (STLN) Q2 2026 Earnings Call Transcript
The Oncology Institute, Inc. (STLN) Reports Q2 Loss, Tops Revenue Estimates